Institutional Ownership Regulus Therapeutics Inc. (RGLS)
This table provides information about the institutional ownership of Regulus Therapeutics Inc. (RGLS). We have compiled data on the 7 institutions that hold shares in the stock, with a total of 4.59 Million shares, which have been reported (via 13F filing form) to have a value of $37.5 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,968,857
shares
|
$32.4 Million
0.0% of portfolio
|
Q2 2024
Added 5733.89%
|
|
|
Cvi Holdings, LLC
Wilmington, DE |
Aug 15, 2024 Q2 2024 |
401,012
shares
|
$3.27 Million
6.25% of portfolio
|
Q2 2024
Reduced 71.48%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
85,602
shares
|
$698,512
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
74,517
shares
|
$608,058
0.0% of portfolio
|
Q1 2025
Reduced 60.87%
|
|
|
Peak6 Investments LLC
Chicago, IL |
Nov 13, 2024 Q3 2024 |
60,000
shares
|
$489,600
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Ifp Advisors, Inc
|
Jul 24, 2025 Q2 2025 |
0
shares
|
$0
0.0% of portfolio
|
Q2 2025
New holding
|